Health Trials

Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）

ConditionUrologic Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

About this trial

This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.

Eligibility criteria

Qualifiers

Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;

Aged > 18 years old;

At least one CT scan or MRI scan before treatment;

Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Disqualifiers

Poor image quality;

Incomplete clinical data or loss of follow-up;

Presence of another primary malignancy other than urologic cancer;

Unclear pathological diagnosis。

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Lead sponsor

Source ClinicalTrials.gov